A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multiple-dose Phase 2 Study to Evaluate the Efficacy and Safety of BMS-986263 in Adults with Compensated Cirrhosis from Nonalcoholic Steatohepatitis (NASH)

Investigator: David Victor, MD

Study Coordinator: Nicole Hinton

Status: Open Not Enrolling

ClinicalTrials.gov Number: NCT04267393

Phone: 281.755.0796

Protocol Number: PRO00029781


The purpose of this randomized study is to assess safety and effectiveness of BMS-986263 in adults with compensated cirrhosis (chronic liver disease) from nonalcoholic steatohepatitis (fatty liver disease) (NASH).
More to Explore